The cost-effectiveness of paclitaxel (Taxol) + cisplatin is similar to that of teniposide + cisplatin in advanced non-small cell lung cancer: a multicountry analysis. (Q33333058)
Jump to navigation
Jump to search
scientific article published in July 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | The cost-effectiveness of paclitaxel (Taxol) + cisplatin is similar to that of teniposide + cisplatin in advanced non-small cell lung cancer: a multicountry analysis. |
scientific article published in July 1999 |
Statements
The cost-effectiveness of paclitaxel (Taxol) + cisplatin is similar to that of teniposide + cisplatin in advanced non-small cell lung cancer: a multicountry analysis (English)
L Annemans
G Giaccone